Oaktree Capital Management

Oaktree Capital Management is a privately owned investment manager specializing in alternative investment strategies.

Business Model:

Revenue: $709.5M

Employees: 1,001-5,000

Rankings

Detailed Oaktree Capital Management Information

Oaktree Capital Management was acquired by Brookfield Asset Management.
The acquisition happend on 2019-03-13.
Details of the transaction were not public

Geographic Data

Oaktree Capital Management headquarters map

Address: 333 South Grand Avenue

City: Los Angeles

State: CA

Zip: 90071

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$36B

Metrics

320,238Website Global Rank

183,165Website Monthly Traffic

Twitter Followers

Description

Oaktree’s mission is to provide highly professional management with a primary emphasis on risk control in a limited number of sophisticated investment specialties. Oaktree specializes in less efficient markets and alternative investments, and has extensive experience, an enviable track record, broad product range and substantial assets under management. They are dedicated to the achievement of consistent and superior performance without high risk. Their ultimate objective is investment success, the fruits of which are shared by Oaktree’s clients and personnel.

Contact Phone:
+12138306300

Contact Email:

Oaktree Capital Management went public on 4/12/2012 on the NYSE

Listed Exchange:
NYSE

IPO Date:
4/12/2012

IPO Valuation:
$1B

Ticker Symbol:
OAK

IPO Price:
$43/share

Amount Raised:
$380M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
10/2011 Panrico SA Debt Financing -
10/2021 Thrasio Series D 0
3/2021 NN Post-IPO Equity 265M
11/2016 Sterling Lumber Company Venture Round -
1/2022 Unblocked Seed Round 0
2/2018 Kudu Investment Management Funding Round 0
6/2004 Infraworks Series B 7.5M
9/2020 Zzoomm Full Fibre Broadband Series B 128.7M
4/2021 Thrasio Series C 0
4/2014 Enplug Seed Round 0
3/2021 RumbleON Post-IPO Equity 280M
3/2016 ProService Finteco Private Equity Round -
7/2018 cure.fit Series C 120M
10/2018 Montrose Private Equity Round -
8/2021 Environmental 360 Solutions E360S Venture Round -
10/2016 SunOpta Post-IPO Equity 85M
10/2022 scPharmaceuticals Post-IPO Debt 100M
4/2015 ezbob Debt Financing 45.2M
9/2020 Universal Plant Services Secondary Market -
2/2021 Thrasio Series C 750M
4/2020 SunOpta Post-IPO Equity 0
1/2014 Ten K Solar Venture Round 0
7/2019 Singular Venture Round -
2/2021 Win Brands Group Equity 50M
4/2022 BioXcel Therapeutics Post-IPO Equity 5M
11/2021 Elevate Brands Venture Round 0
9/2019 Mission Lane Debt Financing 300M
6/2019 Costa Edutainment Secondary Market 45.5M
10/2018 Assembled Brands Funding Round 100M
12/2021 Cvent Post-IPO Equity 0
10/2018 Blue Sky Private Equity Post-IPO Debt 35.9M
11/2012 Pulse Electronics Post-IPO Equity 102.7M
12/2020 System One Private Equity Round -
7/2017 DDH1 Venture Round -
1/2021 Thrasio Debt Financing 0
3/2016 FortiFi Series A 75M
12/2021 HealthCare.com Series C 0
12/2019 Marinus Pharmaceuticals Equity 30M
3/2018 Proserv Private Equity Round 50M
6/2016 Tribes Venture Round -
3/2016 ezbob Series C 28.8M
2/2022 b atomic Seed 1M
10/2021 Mission Lane Debt Financing 150M
5/2021 Marinus Pharmaceuticals Post-IPO Debt 45M
1/2022 ABC Technologies Post-IPO Equity 269.5M
6/2019 SHINE Medical Technologies Debt 50M
2/2022 Draslovka Private Equity Round 0
3/2022 Impel NeuroPharma Post-IPO Debt 50M
3/2013 Charter Communications Post-IPO Equity -
4/2020 Airbnb Debt Financing 1B
12/2021 Montana Renewables Debt Financing 300M
4/2022 BioXcel Therapeutics Post-IPO Debt 135M
11/2020 REEF Private Equity Round 700M
6/2019 cure.fit Series D 120M
9/2021 Priority Power Management Private Equity Round 250M
7/2020 M3M India Limited Debt Financing 76M
12/2021 SiO2 Materials Science Debt 205M
12/2020 BKV Corporation Venture Round 100M
12/2020 brumbrum Debt Financing 65M
6/2021 Primary Wave Private Equity Round -
9/2016 ICICI Prudential Life Insurance Private Equity Round 0
3/2021 SumUp Debt Financing 0
7/2016 Array Technologies Seed Round -
8/2020 Fortress Biotech Post-IPO Debt 60M
4/2022 BioXcel Therapeutics Post-IPO Debt 0
4/2022 BioXcel Therapeutics Post-IPO Equity 0
3/2022 Marinus Pharmaceuticals Post-IPO Debt 0
3/2022 Impel NeuroPharma Post-IPO Debt 0
2/2022 b atomic Seed Round 0
2/2022 Draslovka Private Equity Round 0
1/2022 Unblocked Seed Round 0
1/2022 ABC Technologies Post-IPO Equity 0
12/2021 SiO2 Materials Science Debt Financing 0
12/2021 HealthCare.com Series C 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research